MIM
CRBU icon

Monashee Investment Management’s Caribou Biosciences CRBU Stock Holding History

Monashee Investment Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-470,000
Closed -$4.32M – 32
2022
Q1 		$4.32M Sell
470,000
-34,377
-7% -$362K 1.25% 7
2021
Q4 		$7.61M Buy
504,377
+55,000
+12% +$1.07M 1.88% 6
2021
Q3 		$10.7M Buy
+449,377
New +$11M 1.98% 3

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Monashee Investment Management's CRBU Position: Q2 2022 in Review

Monashee Investment Management sold out of Caribou Biosciences (CRBU) in Q2 2022, closing a stake of 470,000 shares — an estimated $4.32M sold.

Monashee Investment Management first reported a position in CRBU in Q3 2021 and held it in 3 quarters. The position peaked at $10.7M in Q3 2021. 120 funds tracked by Wall St. Rank hold CRBU as of Q2 2022.

  • Monashee Investment Management reported no remaining Caribou Biosciences position as of Q2 2022 after selling out during the quarter.
  • Monashee Investment Management sold 470,000 Caribou Biosciences shares in Q2 2022, an estimated $4.32M.
  • Monashee Investment Management first reported a position in Caribou Biosciences in Q3 2021 and held it in 3 quarters.
  • Monashee Investment Management's Caribou Biosciences position peaked at $10.7M in Q3 2021.
  • 120 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2022.

Based on Monashee Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.